WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

NAV: 29 Oct '26
₹17.29
Min. for SIP
₹100
Fund size (AUM)
₹1,002.75 Cr
Expense ratio
1.07%
Rating
--

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
3 months₹15,000₹14,954
-0.31%
6 months₹30,000₹31,050
+3.50%
1 year₹60,000₹66,852
+11.42%

Holdings (67)

NameSectorInstrumentsAssets
Divi's Laboratories LtdHealthcareEquity7.73%
Sun Pharmaceutical Industries LtdHealthcareEquity6.57%
Torrent Pharmaceuticals LtdHealthcareEquity5.78%
Others CBLOUnspecifiedCBLO5.13%
Laurus Labs LtdHealthcareEquity3.61%
Apollo Hospitals Enterprise LtdHealthcareEquity3.47%
Cipla LtdHealthcareEquity3.40%
Sai Life Sciences Ltd.HealthcareEquity3.03%
Ipca Laboratories LtdHealthcareEquity2.66%
Zydus Lifesciences LtdHealthcareEquity2.60%
Neuland Laboratories LtdHealthcareEquity2.40%
Dr. Lal Pathlabs LtdHealthcareEquity2.17%
CORONA Remedies Ltd.HealthcareEquity2.16%
Thyrocare Technologies LtdHealthcareEquity2.10%
Aurobindo Pharma LtdHealthcareEquity1.93%
Dr. Reddy's Laboratories Ltd FuturesHealthcareFutures1.91%
Ajanta Pharma LtdHealthcareEquity1.86%
Cipla Ltd FuturesHealthcareFutures1.71%
Krishna Institute Of Medical Sciences LtdHealthcareEquity1.71%
Max Healthcare Institute LtdHealthcareEquity1.70%
Shaily Engineering Plastics LtdMaterialsEquity1.70%
Global Health LtdHealthcareEquity1.68%
Narayana Hrudayalaya LtdHealthcareEquity1.49%
Anthem Biosciences Ltd.HealthcareEquity1.45%
Aurobindo Pharma Ltd FuturesHealthcareFutures1.44%
Vijaya Diagnostic Centre LtdHealthcareEquity1.44%
Onesource Specialty Pharma LtdHealthcareEquity1.43%
Ami Organics LtdHealthcareEquity1.34%
Navin Fluorine International LtdMaterialsEquity1.31%
Laurus Labs LimitedHealthcareFutures1.30%
Fortis Healthcare LtdHealthcareEquity1.26%
Aarti Pharmalabs Ltd.HealthcareEquity1.11%
Mankind Pharma Ltd.HealthcareEquity1.11%
Procter & Gamble Health LtdHealthcareEquity1.09%
Molbio Diagnostics Ltd.HealthcareEquity1.06%
Rainbow Childrens Medicare LtdHealthcareEquity1.06%
Mankind Pharma Ltd.HealthcareFutures1.04%
Piramal Pharma LtdHealthcareEquity0.98%
Aether Industries LtdMaterialsEquity0.97%
Kovai Medical Center & Hospital LtdHealthcareEquity0.88%
Gland Pharma LtdHealthcareEquity0.86%
Senores Pharmaceuticals Ltd.HealthcareEquity0.74%
Jupiter Life Line Hospitals Ltd.HealthcareEquity0.67%
Supriya Lifescience LtdHealthcareEquity0.64%
Vimta Labs LtdHealthcareEquity0.62%
Innova Captab Ltd.HealthcareEquity0.59%
GOVERNMENT OF INDIA 37816 091 DAYS TBILL 05NV26 FV RS 100FinancialTreasury Bills0.56%
91 Days Treasury Bill 03-Dec-2026FinancialTreasury Bills0.55%
Nephrocare Health Services Ltd.HealthcareEquity0.53%
Net ReceivablesUnspecifiedNet Receivables0.53%
91 DAYS TBILL RED 10-12-2026FinancialTreasury Bills0.49%
Manipal Health Enterprises LtdHealthcareEquity0.48%
GOVERNMENT OF INDIA 37424 182 DAYS TBILL 05NV26 FV RS 100FinancialTreasury Bills0.44%
Sudeep Pharma Ltd.HealthcareEquity0.42%
Biocon LtdHealthcareEquity0.39%
Tatva Chintan Pharma Chem LtdMaterialsEquity0.38%
Orchid Pharma LtdHealthcareEquity0.38%
Zota Health Care LtdHealthcareEquity0.37%
GOVERNMENT OF INDIA 37705 091 DAYS TBILL 29OT26 FV RS 100FinancialTreasury Bills0.34%
GOVERNMENT OF INDIA 37846 091 DAYS TBILL 19NV26 FV RS 100FinancialTreasury Bills0.30%
Novartis India LtdHealthcareEquity0.22%
Laxmi Dental Ltd.HealthcareEquity0.21%
Apollo Hospitals Enterprise Ltd FuturesHealthcareFutures0.19%
GOVERNMENT OF INDIA 37693 091 DAYS TBILL 22OT26 FV RS 100FinancialTreasury Bills0.16%
Bharat Parenterals LtdHealthcareEquity0.09%
GOVERNMENT OF INDIA 37436 182 DAYS TBILL 12NV26 FV RS 100FinancialTreasury Bills0.07%
GOVERNMENT OF INDIA 36692 364 DAYS TBILL 06NV26 FV RS 100FinancialTreasury Bills0.01%

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100

Returns and rankings

Name3M6M1YAll
Fund returns+0.2%+17.0%+18.2%+72.9%
Category average (Equity Sectoral)-2.1%+11.9%+13.7%+180.7%
Rank (Equity Sectoral)424--

Exit load, stamp duty and tax

Exit load

Nil

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

Education
Mr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.
Experience
Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
Also manages these schemes

About WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Ramesh Mantri is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹47,816 Cr and the Latest NAV as of 29 Oct 2026 is ₹17.29. The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500. ;

Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)--
Total AUM₹47,815.95 Cr
Date of Incorporation03 Jul 2018
Phone1800 266 3060
E-mail--
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
CustodianDeutsche Bank
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,